A first-of-its-kind organization launched on May 13 unifying the voices of life science companies committed to delivering desperately needed treatments to rare disease patients. The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and have more than 160 rare disease programs in the works.
EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.
As we continue to sift through the barrage of information regarding survival rates, resurgence, vaccines, and secondary illnesses, COVID-19 and its economic impact continues to be a primary global burden. In the midst of those serious concerns, the health and life sciences (HLS) industry continues its accelerated journey of perpetual assessment and evolution. As the industry emerges from the pandemic effect, leaders are realizing that COVID-19 has provided crucial learnings to their organizations that will benefit the entire industry, according to Astound Commerce’s Tina Wilson.
Havas Health & You announced that HH&Y is the first health network to become a Global Content Partner as part of Veeva Systems’ Content Partner Program.
Life sciences consulting firm Beghou Consulting promoted nine associate partners to partner. Based out of the firm’s Chicago, New York, San Francisco, Boston and Raleigh-Durham offices, the new partners specialize in commercial analytics, data management, customer targeting, forecasting, incentive compensation and more.
Komodo Health and Klick Health on April 8 announced a strategic partnership making Klick the premier life sciences marketing agency to leverage Komodo’s Healthcare Map – a real-world data and analytics platform.
Leading life science commercialization partner Fishawack Health acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the United States.
Precision Value & Health, an industry leader for commercialization services for innovative life science companies, on March 24 announced the acquisition of Across Health, a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution and resource optimization.
A global pandemic has left life sciences companies with giant targets on their backs for cyberattacks.
Fishawack Health, a leading commercialization partner for the life science industry, appointed former Covance CEO Deborah Keller as the new Chair of its board.
